Sinopharm to Produce 5b Doses Per Year with Foreign Partners: Firm Executives

By Huang Lanlan in Shanghai and Leng Shumei in Beijing

May 13, 2021 11:43 PM

Sinopharm Photo:VCG

China's Sinopharm is expanding the production capacity to five billion doses per year with accelerating overseas cooperation after one of its COVID-19 vaccines was included in the Emergency Using List of the World Health Organization (WHO), company executives said at a forum on Thursday in Shanghai. 

Sinopharm has produced more than 400 million doses of COVID-19 vaccines and more than 200 million doses have been supplied at home and abroad, Sinopharm executives said.   

Sinopharm is expected to further expand its production capacity to five billion doses of COVID-19 vaccines per year globally as the Chinese pharmaceutical giant is working on the construction and expansion of vaccine-producing plants, and cooperating with foreign countries, including the UAE, to make Sinopharm vaccine overseas, according to Sinopharm chairman Liu Jingzhen.

More than 100 countries and international organizations have expressed interest in China's Sinopharm COVID-19 vaccine, said Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), a Sinopharm subsidiary. 

The vaccine has been registered for market or approved for emergency use by 80 countries, regions and international organizations, covering people from 196 countries [and regions], Yang said at a Sinopharm COVID-19 vaccine-themed forum in Shanghai on Thursday.

"The Sinopharm vaccine has become the world's safest, most widely-used and acclaimed COVID-19 vaccine," Yang noted.    

Sinopharm have created three COVID-19 vaccines, including two inactivated and one recombinant one. The two inactivated vaccines have been approved for market by Chinese authorities and been used widely around the world, while the recombinant one is under Phase I/II clinical trials that kicked off in Central China's Henan Province in April. 

One of the two inactivated vaccines made by a Beijing-based institute under the CNBG obtained emergency approval from the WHO on May 7.   

WHO's approval would be a stepping stone and key for Sinopharm to promote their COVID-19 vaccines in the international market, company executives said at the forum.

The WHO experts' final report on the Sinopharm vaccines said that the experts have low confidence in the vaccine's efficacy on people aged 60 and above and other groups with underlying diseases. 

A domestic trial covering more than 100,000 volunteers, of which 40 percent will be elderly people, to observe our vaccines' safety and side effects on these groups will be conducted. Data on research on those aged 3-17 have been obtained and submitted to the national authority, Zhang Yuntao, CNBG vice president and chief scientist, said at the forum. 

Thirteen women have gotten pregnant after getting Sinopharm's shots and one of them gave birth to a healthy baby this month, which shows promise for pregnant women in the future, Zhang said.

Research on simultaneous vaccinations of COVID-19 vaccines and vaccines against other respiratory diseases is also underway. Dose studies on people with underlying diseases such as diabetes, high blood pressure and AIDS are also being conducted, according to Zhang.

No comments

Thank you for reaching out to us. We are happy to receive your opinion and request. If you are need advert or sponsored post, We’re excited you’re considering advertising or sponsoring a post on our blog. Your support is what keeps us going. With the current trend, it’s very obvious content marketing is the way to go. Banner advertising and trying to get customers through Google Adwords may get you customers but it has been proven beyond doubt that Content Marketing has more lasting benefits.
We offer majorly two types of advertising:
1. Sponsored Posts: If you are really interested in publishing a sponsored post or a press release, video content, advertorial or any other kind of sponsored post, then you are at the right place.
Generally, a sponsored post can be any of the following:
Press release
Video content
This kind of post is usually written to promote you or your business. However, we do prefer posts that naturally flow with the site’s general content. This means we can also promote artists, songs, cosmetic products and things that you love of all products or services.
Every sponsored article will remain live on the site as long as this website exists. The duration is indefinite! Again, we will share your post on our social media channels and our email subscribers too will get to read your article. You’re exposing your article to our: Twitter followers, Facebook fans and other social networks.

We will also try as much as possible to optimize your post for search engines as well.

Submission of Materials : Sponsored post should be well written in English language and all materials must be delivered via electronic medium. All sponsored posts must be delivered via electronic version, either on disk or e-mail on Microsoft Word unless otherwise noted.
The price largely depends on if you’re writing the content or we’re to do that. But if your are writing the content, it is $60 per article.

2. Banner Advertising: We also offer banner advertising in various sizes and of course, our prices are flexible. you may choose to for the weekly rate or simply buy your desired number of impressions.

Technical Details And Pricing
Banner Size 300 X 250 pixels : Appears on the home page and below all pages on the site.
Banner Size 728 X 90 pixels: Appears on the top right Corner of the homepage and all pages on the site.
Large rectangle Banner Size (336x280) : Appears on the home page and below all pages on the site.
Small square (200x200) : Appears on the right side of the home page and all pages on the site.
Half page (300x600) : Appears on the right side of the home page and all pages on the site.
Portrait (300x1050) : Appears on the right side of the home page and all pages on the site.
Billboard (970x250) : Appears on the home page.

Submission of Materials : Banner ads can be in jpeg, jpg and gif format. All materials must be deliverd via electronic medium. All ads must be delivered via electronic version, either on disk or e-mail in the ordered pixel dimensions unless otherwise noted.
For advertising offers, send an email with your name,company, website, country and advert or sponsored post you want to appear on our website to omodjk(at)gmail(dot)com

Normally, we should respond within 48 hours.

Sponsored Partner's Advertisement